- Home
- Products
- Customized FluoroAb™
- C5
- Anti-C5 MAb (Clone 1)-iFluor® 405 Succinimidyl Ester
Anti-C5 MAb (Clone 1)-iFluor® 405 Succinimidyl Ester (CAT#: WJY0-LS2120)
This product is comprised of an Humanized Anti-C5 IgG2/G4-kappa antibody (Clone 1) labeled with iFluor® 405 Succinimidyl Ester. iFluor® 405 Succinimidyl Ester is a Blue-fluorescent dye and it's excitation/emission is 403/427 nm.
- TARGET
- ANTIBODY
- DYE
- Name
- C5
- Alternative Names
- C5; complement component 5; complement C5; CPAMD4; anaphylatoxin C5a analog; C3 and PZP-like alpha-2-macroglobulin domain-containing protein 4; FLJ17816; FLJ17822; MGC142298;
- Overview
- This gene encodes a component of the complement system, a part of the innate immune system that plays an important role in inflammation, host homeostasis, and host defense against pathogens. The encoded preproprotein is proteolytically processed to generate multiple protein products, including the C5 alpha chain, C5 beta chain, C5a anaphylatoxin and C5b. The C5 protein is comprised of the C5 alpha and beta chains, which are linked by a disulfide bridge. Cleavage of the alpha chain by a convertase enzyme results in the formation of the C5a anaphylatoxin, which possesses potent spasmogenic and chemotactic activity, and the C5b macromolecular cleavage product, a subunit of the membrane attack complex (MAC). Mutations in this gene cause complement component 5 deficiency, a disease characterized by recurrent bacterial infections. Alternative splicing results in multiple transcript variants.
- Overview
- Humanized Anti-C5 IgG2/G4-kappa antibody (Clone 1)
- Species Reactivity
- Human
- Name
- iFluor® 405 Succinimidyl Ester
- Color
- Blue
- Excitation⁄Emission (nm)
- 403/427
- Detection method
- Fluorescent
For Research Use Only. NOT FOR CLINICAL USE.
Related Products
- Anti-HBV MAb (Clone 1)-iFluor® 514 Succinimidyl Ester (CAT#: WJY0-LS11506)
- Anti-IL22 MAb (Clone 1)-iFluor® 460 Succinimidyl Ester (CAT#: WJY0-LS8316)
- Farletuzumab-Bodipy FL (CAT#: ADC-FL-1542)
- Anti-DLL4 MAb (Clone 5)-iFluor® 430 Succinimidyl Ester (CAT#: WJY0-LS4327)
- Anti-PCSK9 MAb (Clone 2)-iFluor® 430 Succinimidyl Ester (CAT#: WJY0-LS3756)
- Anti-CD22 MAb (Clone 7)-iFluor® 460 Succinimidyl Ester (CAT#: WJY0-LS8021)
- Anti-IL6 MAb (Clone 6)-iFluor® 460 Succinimidyl Ester (CAT#: WJY0-LS8458)
- Anti-IgG Fc MAb (Clone 3)-iFluor® 555 Succinimidyl Ester (CAT#: WJY0-LS15947)
- Anti-CD4 MAb (Clone 35)-iFluor® 514 Succinimidyl Ester (CAT#: WJY0-LS11934)
- Anti-ERBB2 MAb (Clone 5)-iFluor® 514 Succinimidyl Ester (CAT#: WJY0-LS11118)
Published Data
+ Submit Publications
Scientific Resources
Customer Reviews and FAQs
There are currently no Customer reviews or questions for WJY0-LS2120. Click the button above to contact us or submit your feedback about this product.
Quick Links
Other Products
Same Target
| CAT# | Product Name | Linker | Payload |
| ADC-W-731 | Anti-C5 (Eculizumab)-MC-Vc-PAB-MMAE ADC | MC-Vc-PAB (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl) | MMAE |
| ADC-W-730 | Anti-C5 (Eculizumab)-MC-MMAF ADC | MC (maleimidocaproyl) | MMAF |
| ADC-W-735 | Anti-C5 (Pexelizumab)-SPDB-DM4 ADC | SPDB (N-succinimidyl-4-(2-pyridyldithio)butyrate) | DM4 (N2'-Deacetyl-N2'-(4-mercapto-4-methyl-1-oxopentyl)maytansine) |
| ADC-W-739 | Anti-C5 (Pexelizumab)-MC-Vc-PAB-DMEA-(PEG2)-duocarmycin SA ADC | MC-Vc-PAB-DMEA-(PEG2) | duocarmycin SA |
| ADC-W-734 | Anti-C5 (Pexelizumab)-SMCC-DM1 ADC | SMCC (N-succinimidyl 4-(Nmaleimidomethyl)cyclohexane-1-carboxylate) | DM1 (N2'-Deacetyl-N2'-(3-mercapto-1-oxopropyl)maytansine) |
Online Inquiry
Welcome! For price inquiries, please feel free to contact us through the form on the left side. We will get back to you as soon as possible.
